HC Wainwright & Co. downgrades Bausch & Lomb to Neutral from Buy, raises price target to $22 from $21

What happened

HC Wainwright & Co. downgraded Bausch & Lomb from Buy to Neutral while raising its price target from $21 to $22. The new target is 4.8% higher and implies 10.0% upside from the October 30 closing price of $20.

Confirmed

Global impact / market context

The downgrade signals that HC Wainwright is less positive about Bausch & Lomb’s prospects, even as its higher target suggests some expected share-price gain. A change in analyst opinion can influence investor positioning, but the article gives no evidence of a company or operating change.

Analyst inference

The five analyst notes listed for the past 30 days set targets from $19 to $24. HC Wainwright’s $22 target sits within that range, alongside other listed ratings from Neutral to Buy and Outperform; these are analyst views, not company results or guaranteed outcomes.

Confirmed

What to watch

1. Check whether Bausch & Lomb later reports changes in sales, costs, or cash available; such operating results could explain whether the analyst’s more cautious rating is warranted. Analyst inference
2. Watch for further analyst rating or target changes, since revisions could shift investor expectations; the article lists several recent opinions but makes no forecast about future changes. Analyst inference
3. Compare future company updates with the stated $22 target and the listed $19–$24 range, while remembering that targets express analysts’ estimates rather than assured share prices. Analyst inference

Evidence

• Original source link unavailable